[go: up one dir, main page]

IT1304183B1 - Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici. - Google Patents

Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.

Info

Publication number
IT1304183B1
IT1304183B1 IT1998MI002732A ITMI982732A IT1304183B1 IT 1304183 B1 IT1304183 B1 IT 1304183B1 IT 1998MI002732 A IT1998MI002732 A IT 1998MI002732A IT MI982732 A ITMI982732 A IT MI982732A IT 1304183 B1 IT1304183 B1 IT 1304183B1
Authority
IT
Italy
Prior art keywords
complexes
proantocyanidine
agentiantiaterosclerotici
phospholipides
proanthocyanidin
Prior art date
Application number
IT1998MI002732A
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT1998MI002732A priority Critical patent/IT1304183B1/it
Application filed by Indena Spa filed Critical Indena Spa
Priority to PL349534A priority patent/PL197153B1/pl
Priority to EP99966956A priority patent/EP1140115B1/en
Priority to CNB998144460A priority patent/CN1146429C/zh
Priority to JP2000589173A priority patent/JP4842436B2/ja
Priority to HU0104665A priority patent/HU228928B1/hu
Priority to CA002355776A priority patent/CA2355776C/en
Priority to US09/857,804 priority patent/US6429202B1/en
Priority to PT99966956T priority patent/PT1140115E/pt
Priority to IL14375199A priority patent/IL143751A0/xx
Priority to AU22830/00A priority patent/AU763907B2/en
Priority to SK860-2001A priority patent/SK284884B6/sk
Priority to SI9930268T priority patent/SI1140115T1/xx
Priority to AT99966956T priority patent/ATE238803T1/de
Priority to CZ20012134A priority patent/CZ301495B6/cs
Priority to ES99966956T priority patent/ES2197708T3/es
Priority to PCT/EP1999/009854 priority patent/WO2000037062A2/en
Priority to HK02103200.8A priority patent/HK1042430B/zh
Priority to RU2001116085/15A priority patent/RU2248798C2/ru
Priority to KR1020017007374A priority patent/KR100694907B1/ko
Priority to DK99966956T priority patent/DK1140115T3/da
Priority to DE69907509T priority patent/DE69907509T2/de
Publication of ITMI982732A1 publication Critical patent/ITMI982732A1/it
Application granted granted Critical
Publication of IT1304183B1 publication Critical patent/IT1304183B1/it
Priority to IL143751A priority patent/IL143751A/en
Priority to NO20012944A priority patent/NO328733B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT1998MI002732A 1998-12-18 1998-12-18 Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici. IT1304183B1 (it)

Priority Applications (24)

Application Number Priority Date Filing Date Title
IT1998MI002732A IT1304183B1 (it) 1998-12-18 1998-12-18 Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
AT99966956T ATE238803T1 (de) 1998-12-18 1999-12-13 Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
CNB998144460A CN1146429C (zh) 1998-12-18 1999-12-13 用作抗动脉粥样硬化剂的原花色素a2的磷脂复合物
JP2000589173A JP4842436B2 (ja) 1998-12-18 1999-12-13 抗アテローム硬化剤としてのプロアントシアニジンa2リン脂質複合体
HU0104665A HU228928B1 (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
CA002355776A CA2355776C (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
US09/857,804 US6429202B1 (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin A2 as antiatherosclerotic agents
PT99966956T PT1140115E (pt) 1998-12-18 1999-12-13 Complexos fosfolipidicos de proantocianidin a2 como agentes anti-ateroscleroticos
IL14375199A IL143751A0 (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
AU22830/00A AU763907B2 (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin A2 as antiatherosclerotic agents
SK860-2001A SK284884B6 (sk) 1998-12-18 1999-12-13 Fosfolipidové komplexy proantokyanidínu A2, farmaceutický prostriedok s ich obsahom a ich použitie
SI9930268T SI1140115T1 (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
PL349534A PL197153B1 (pl) 1998-12-18 1999-12-13 Fosfolipidowe kompleksy proantocyjanidyny A2, ich zastosowanie oraz kompozycja zawierająca taki kompleks
CZ20012134A CZ301495B6 (cs) 1998-12-18 1999-12-13 Fosfolipidové komplexy
KR1020017007374A KR100694907B1 (ko) 1998-12-18 1999-12-13 아테롬성동맥경화 치료제로서의 프로안토시아니딘 a2의인지질 착체
PCT/EP1999/009854 WO2000037062A2 (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
HK02103200.8A HK1042430B (zh) 1998-12-18 1999-12-13 用作抗動脈粥樣硬化劑的原花色素a2的磷脂復合物
RU2001116085/15A RU2248798C2 (ru) 1998-12-18 1999-12-13 Фосфолипидные комплексы проантоцианидина а2 в качестве антиатеросклеротических агентов
ES99966956T ES2197708T3 (es) 1998-12-18 1999-12-13 Complejos fosfolipidicos de proantocianidina a2 como agentes antiateroscleroticos.
EP99966956A EP1140115B1 (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
DE69907509T DE69907509T2 (de) 1998-12-18 1999-12-13 Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
DK99966956T DK1140115T3 (da) 1998-12-18 1999-12-13 Phospholipidkomplekser af proanthocyanidin A2 som antiatherosclerotiske midler
IL143751A IL143751A (en) 1998-12-18 2001-06-13 Phospholipid complexes of proanthocyanidin A2 that act as anti-atherosclerotic substances
NO20012944A NO328733B1 (no) 1998-12-18 2001-06-14 Fosfolipidkomplekser av proantocyanidin A2, farmasoytisk sammensetning inneholdende kompleksene og anvendelse derav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002732A IT1304183B1 (it) 1998-12-18 1998-12-18 Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.

Publications (2)

Publication Number Publication Date
ITMI982732A1 ITMI982732A1 (it) 2000-06-18
IT1304183B1 true IT1304183B1 (it) 2001-03-08

Family

ID=11381268

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998MI002732A IT1304183B1 (it) 1998-12-18 1998-12-18 Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.

Country Status (22)

Country Link
US (1) US6429202B1 (it)
EP (1) EP1140115B1 (it)
JP (1) JP4842436B2 (it)
KR (1) KR100694907B1 (it)
CN (1) CN1146429C (it)
AT (1) ATE238803T1 (it)
AU (1) AU763907B2 (it)
CA (1) CA2355776C (it)
CZ (1) CZ301495B6 (it)
DE (1) DE69907509T2 (it)
DK (1) DK1140115T3 (it)
ES (1) ES2197708T3 (it)
HK (1) HK1042430B (it)
HU (1) HU228928B1 (it)
IL (2) IL143751A0 (it)
IT (1) IT1304183B1 (it)
NO (1) NO328733B1 (it)
PL (1) PL197153B1 (it)
PT (1) PT1140115E (it)
RU (1) RU2248798C2 (it)
SK (1) SK284884B6 (it)
WO (1) WO2000037062A2 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507018B2 (en) 1998-03-12 2013-08-13 Mars, Incorporated Products containing polyphenol(s) and L-arginine and methods of use thereof
EP1482920B2 (en) * 2002-02-12 2011-07-20 Hunza di Pistolesi Elvira & C. S.a.S. Compositions containing n-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
JP5456955B2 (ja) * 2004-01-28 2014-04-02 マース インコーポレーテッド Aタイプのプロシアニジンを含有する組成物およびその使用方法
EP1837030A1 (en) 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability
WO2009104556A1 (ja) * 2008-02-19 2009-08-27 株式会社岐阜セラツク製造所 組成物
IT1398624B1 (it) * 2009-02-02 2013-03-08 Dermogyn S R L Uso cosmetico della proantocianidina a2
RU2456674C1 (ru) * 2011-05-31 2012-07-20 Тагир Уралович Гафаров Способ моделирования атрофического рубца кожи
CN102688501A (zh) * 2012-06-20 2012-09-26 浙江萧山医院 原花青素b2磷脂复合物及其制备方法和用途
CN103120798A (zh) * 2013-01-10 2013-05-29 施冬云 一种具有抗氧化应激作用的磷脂复合物制备方法及其应用
CN103467778B (zh) * 2013-09-06 2015-09-30 天津大学 细菌纤维素/卵磷脂复合材料及制备和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360B1 (en) 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
BR9106784A (pt) * 1990-08-20 1993-06-29 Gerhard Ohlenschlager Mistura de substancias,terapeuticamente ativa,de compostos de glutationa e antociano
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
US5648377A (en) 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
IT1270999B (it) * 1994-07-26 1997-05-26 Indena Spa Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico
FI955691L (fi) 1994-11-28 1996-05-29 Suntory Ltd Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet
IT1296920B1 (it) * 1997-12-04 1999-08-03 Indena Spa Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
EP1210785B1 (de) 1999-09-08 2005-11-23 Siemens Aktiengesellschaft Anordnung und verfahren für eine optische informationsübertragung

Also Published As

Publication number Publication date
DK1140115T3 (da) 2003-08-25
CZ301495B6 (cs) 2010-03-24
IL143751A0 (en) 2002-04-21
ATE238803T1 (de) 2003-05-15
HU228928B1 (en) 2013-06-28
CA2355776A1 (en) 2000-06-29
ITMI982732A1 (it) 2000-06-18
WO2000037062A3 (en) 2000-08-03
NO20012944L (no) 2001-06-14
DE69907509D1 (en) 2003-06-05
NO328733B1 (no) 2010-05-03
PL197153B1 (pl) 2008-03-31
PT1140115E (pt) 2003-08-29
SK8602001A3 (en) 2001-12-03
JP4842436B2 (ja) 2011-12-21
KR20010093826A (ko) 2001-10-29
KR100694907B1 (ko) 2007-03-14
HUP0104665A3 (en) 2003-01-28
ES2197708T3 (es) 2004-01-01
SK284884B6 (sk) 2006-02-02
WO2000037062A2 (en) 2000-06-29
CN1146429C (zh) 2004-04-21
EP1140115A2 (en) 2001-10-10
IL143751A (en) 2006-07-05
CZ20012134A3 (cs) 2001-12-12
CA2355776C (en) 2008-03-18
JP2002532543A (ja) 2002-10-02
HUP0104665A2 (hu) 2002-04-29
EP1140115B1 (en) 2003-05-02
AU763907B2 (en) 2003-08-07
HK1042430B (zh) 2004-10-08
DE69907509T2 (de) 2004-04-08
AU2283000A (en) 2000-07-12
RU2248798C2 (ru) 2005-03-27
US6429202B1 (en) 2002-08-06
HK1042430A1 (en) 2002-08-16
NO20012944D0 (no) 2001-06-14
CN1330548A (zh) 2002-01-09

Similar Documents

Publication Publication Date Title
DE69940769D1 (de) Orale flüssige zusammensetzungen
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
AU747599C (en) Antitumor agents
DE60001914D1 (de) Mehrzweck zusammensetzungen von säuren
BR9713400A (pt) Processos e compostos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese.
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
DE60118547D1 (de) Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält
EP0214647A3 (en) Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
TR200100047T2 (tr) Tiyobenzimidazol türevleri
BG105880A (en) Compounds useful as anti-inflammatory agents
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
IT1304183B1 (it) Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
ATE356608T1 (de) Behandlung der multiplen sklerose durch einnahme von copolymer-1
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
AU2002303817A1 (en) Compositions and methods for treating or preventing convulsions or seizures
BR0010708A (pt) Glicosìdeos androgênicos e atividade androgênica dos mesmos
NO20040821L (no) 3-substituerte 6,7-dihydroksytetrahydroisokinolinderivater for andvendelse som antibakterielle midler.
DE69606321D1 (de) Stabilisiertes sonnenschutzmittel
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
NO20020914L (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
EA200000531A1 (ru) Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
MXPA04006120A (es) Piperidin-2,6-dionas sustitudas heterociclicamente en posicion 3.